E-Qure Corp. agreed to acquire Bioelectrical Signal Therapy device assets from Michael Cohen for $0.35 million.

E-Qure Corp. is a medical device company that is focused on commercializing its Bioelectrical Signal Therapy Device (BST Device). The BST Device is a non-invasive, painless and easy to use electrotherapy. The Company's non-invasive BST electrical transmission Device mimics the naturally occurring pulses of healing wounds (normal wounds) and creates an electric induction field around the hard-to-heal wound, which accelerates the healing rate. The BST Device stimulates renewed blood flow and oxygen to induce local cell regeneration and therefore promote wound healing. The BST Device is designed to treat chronic wounds, primarily Stage III and Stage IV ulcers. The BST Device is used for the treatment of chronic wounds that include diabetic foot ulcers, vascular (venous or arterial), leg ulcers and pressure (decubitus) ulcers. The BST Device can accelerate healing with rapid wound closure from 45 to 60 days.